Stock listing
NASDAQ:NRX NephroGenex Inc Stock
Follow NephroGenex Inc into a list and get an email when it puts out news.
Last close · NASDAQ:NRX
$0.14 USD
Close on May 10, 2016 · No longer trades
- Lowest – highest close
- $0.12 – $13.35 USDSince Feb 12, 2014 · lowest May 5, 2016 · highest Dec 31, 2014
Delisted NASDAQ:NRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
NephroGenex Inc on 6ix
- Decks
- 14 decks · latest Jul 6, 2016
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (July 2016) | Investor deck | 10 slides | Jul 6, 2016 |
| Investor Presentation (May 2016) | Investor deck | 32 slides | May 13, 2016 |
| Investor Presentation (January 2016) | Investor deck | 43 slides | Jan 7, 2016 |
| Investor Presentation (November 2015) | Investor deck | 40 slides | Nov 12, 2015 |
| Investor Presentation (September 2015) | Investor deck | 31 slides | Sep 2, 2015 |
| Investor Presentation (March 2015) | Investor deck | 28 slides | Mar 26, 2015 |
| Investor Presentation (February 2015) | Investor deck | 30 slides | Feb 24, 2015 |
| Investor Presentation (January 2015) | Investor deck | 29 slides | Jan 6, 2015 |
| Investor Presentation (December 2014) | Investor deck | 29 slides | Dec 11, 2014 |
| Investor Presentation (September 2014) | Investor deck | 25 slides | Sep 2, 2014 |
All 14 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2014) | Investor deck | 24 slides | Aug 29, 2014 |
| Investor Presentation (April 2014) | Investor deck | 22 slides | Apr 29, 2014 |
| Investor Presentation (April 2014) | Investor deck | 22 slides | Apr 9, 2014 |
| IPO Roadshow (January 2014) | IPO roadshow | 33 slides | Jan 21, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Pierre Legault Other companies: Syndax Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2017); Bicycle Therapeutics PLC (Director · May 22, 2019 – Jan 2, 2025 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Mar 26, 2018 · Past); NPS Pharmaceuticals Inc (Director · Nov 3, 2014 – Feb 21, 2015 · Past); Tobira Therapeutics Inc (Director · Nov 18, 2013 – Nov 1, 2016 · Past); Forest Laboratories Inc (Director · Aug 15, 2013 – Jul 1, 2014 · Past) | Chief Executive Officer, Director · Feb 10, 2014 – Nov 10, 2015 · Past |
| Eugen Steiner | Director · Feb 10, 2014 – Dec 9, 2015 · Past |
Log in to ask 6ix AI your own questions about NephroGenex Inc.